Cogent Biosciences Inc.

13.45-0.3600-2.61%Vol 700.88K1Y Perf 71.98%
Aug 11th, 2022 16:00 DELAYED
BID11.65 ASK14.50
Open13.95 Previous Close13.81
Pre-Market- After-Market13.76
 - -  0.31 2.30%
Target Price
17.86 
Analyst Rating
Strong Buy 1.00
Potential %
32.79 
Finscreener Ranking
★+     44.15
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.56
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     38.28
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
92.71 
Earnings Rating
Strong Sell
Market Cap857.01M 
Earnings Date
15th Aug 2022
Alpha0.04 Standard Deviation0.72
Beta2.08 

Today's Price Range

13.4514.58

52W Range

3.7914.21

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
11.62%
1 Month
22.16%
3 Months
243.11%
6 Months
101.95%
1 Year
71.98%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
COGT13.45-0.3600-2.61
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
ProfitabilityValueIndustryS&P 500US Markets
-
-31 649.70
-31 595.20
-540.40
-48.98
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-44.18
-23.18
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.64-0.71-10.94
Q01 2022-0.53-0.68-28.30
Q04 2021-0.55-0.61-10.91
Q03 2021-0.43-0.48-11.63
Q02 2021-0.39-0.43-10.26
Q01 2021-0.46-0.3426.09
Q04 2020-0.30-6.03-1 910.00
Q03 2020-0.19-0.26-36.84
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.64-16.36Negative
9/2022 QR-0.56-1.82Negative
12/2022 FY-2.50-19.62Negative
12/2023 FY-2.24-2.28Negative
Next Report Date15th Aug 2022
Estimated EPS Next Report-0.64
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume700.88K
Shares Outstanding63.72K
Shares Float62.14M
Trades Count10.16K
Dollar Volume9.75M
Avg. Volume1.67M
Avg. Weekly Volume1.24M
Avg. Monthly Volume751.44K
Avg. Quarterly Volume3.00M

Cogent Biosciences Inc. (NASDAQ: COGT) stock closed at 13.45 per share at the end of the most recent trading day (a -2.61% change compared to the prior day closing price) with a volume of 700.88K shares and market capitalization of 857.01M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 72 people. Cogent Biosciences Inc. CEO is Andrews R. Robbins.

The one-year performance of Cogent Biosciences Inc. stock is 71.98%, while year-to-date (YTD) performance is 56.76%. COGT stock has a five-year performance of %. Its 52-week range is between 3.79 and 14.21, which gives COGT stock a 52-week price range ratio of 92.71%

Cogent Biosciences Inc. currently has a PE ratio of -4.80, a price-to-book (PB) ratio of 6.23, a price-to-sale (PS) ratio of 1 116.28, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -41.03%, a ROC of -73.36% and a ROE of -75.50%. The company’s profit margin is -48.98%, its EBITDA margin is -31 595.20%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Cogent Biosciences Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.64 for the next earnings report. Cogent Biosciences Inc.’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for Cogent Biosciences Inc. is Strong Buy (1), with a target price of $17.86, which is +32.79% compared to the current price. The earnings rating for Cogent Biosciences Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cogent Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cogent Biosciences Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.09, ATR14 : 1.01, CCI20 : 217.28, Chaikin Money Flow : 0.14, MACD : 0.91, Money Flow Index : 79.10, ROC : 17.57, RSI : 54.70, STOCH (14,3) : 74.83, STOCH RSI : 0.88, UO : 60.05, Williams %R : -25.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cogent Biosciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (100.00 %)
7 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Cogent Biosciences Inc.

Cogent Biosciences Inc is a biotechnology company. The company is engaged in the development of solutions to treat genetically driven diseases.

CEO: Andrews R. Robbins

Telephone: +1 617 945-5576

Address: 200 Cambridge Park Drive, Cambridge 02140, MA, US

Number of employees: 72

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

Bearish Bullish

52%48%

TipRanks News for COGT


News

Stocktwits